Citation Impact
Citing Papers
Biologic Differences Between Noninvasive Papillary Urothelial Neoplasms of Low Malignant Potential and Low-Grade (Grade 1) Papillary Carcinomas of the Bladder
2001
ESUR prostate MR guidelines 2012
2012 Standout
Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder.
2001
Head and neck squamous cell carcinoma
2020 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Correlation of Ki-67 and p53 With the New World Health Organization/International Society of Urological Pathology Classification System for Urothelial Neoplasia
2001
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
2008 Standout
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Robotic Surgery
2003 Standout
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Robot-assisted versus open radical prostatectomy: a comparison of one surgeon's outcomes
2004 StandoutNobel
Robotics in General Surgery
2003 Standout
Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status
2016
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Molecular Aspects of Bladder Cancer
2002
Measurements of T1‐relaxation in ex vivo prostate tissue at 132 μT
2012 StandoutNobel
Epithelial Cell Plasticity in Development and Tumor Progression
1999
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
2009 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Negative Prostatic Biopsies in Patients with a High Risk of Prostate Cancer
2005
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Hypoxia in cancer: significance and impact on clinical outcome
2007 Standout
GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON
2003
Prevention of Venous Thromboembolism
2004 Standout
A systematic review of intravesical bacillus Calmette‐Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer
2001
TGF-β and fibrosis in different organs — molecular pathway imprints
2009 Standout
Nerve‐sparing robot‐assisted radical cystoprostatectomy and urinary diversion
2003 Standout
Extraperitoneal Laparoscopic Radical Prostatectomy
2001
Flexible transgastric peritoneoscopy: a novel approach to diagnostic and therapeutic interventions in the peritoneal cavity
2004 Standout
P53 as a prognostic marker for bladder cancer: a meta-analysis and review
2005
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Laparoscopic Radical Prostatectomy
2001
Prevention of Venous Thromboembolism
2008 Standout
The clinical management of patients with a small volume of prostatic cancer on biopsy: What are the risks of progression?
2008
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
2015 Standout
Bladder cancer: Epidemiology, staging and grading, and diagnosis
2005 Standout
Prostate Depiction at Endorectal MR Spectroscopic Imaging: Investigation of a Standardized Evaluation System
2004
A prospective comparison of radical retropubic and robot‐assisted prostatectomy: experience in one institution
2003
Robotic radical prostatectomy and the vattikuti urology institute technique: an interim analysis of results and technical points
2003
Epidermal growth factor receptor (EGFR) signaling in cancer
2005 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
1998 Standout
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
Differentiation of Prostatitis and Prostate Cancer by Using Diffusion-weighted MR Imaging and MR-guided Biopsy at 3 T
2013
Head and Neck Cancer
2001 Standout
LAPAROSCOPIC RADICAL PROSTATECTOMY WITH A REMOTE CONTROLLED ROBOT
2001
Robotic radical prostatectomy: A technique to reduce pT2 positive margins
2004 StandoutNobel
Vattikuti Institute Prostatectomy: A Single-Team Experience of 100 Cases
2003
CLASSIFICATION AND TRENDS OF PERIOPERATIVE MORBIDITIES FOLLOWING LAPAROSCOPIC RADICAL PROSTATECTOMY
2005
LAPAROSCOPIC RADICAL PROSTATECTOMY
2005
Continuum Robots for Medical Applications: A Survey
2015 Standout
Laparoscopic Radical Prostatectomy
2001
Prostate Cancer Localization with Dynamic Contrast-enhanced MR Imaging and Proton MR Spectroscopic Imaging
2006
Successful Transfer of Open Surgical Skills to a Laparoscopic Environment Using a Robotic Interface: Initial Experience With Laparoscopic Radical Prostatectomy
2003
Laparoscopic Radical Prostatectomy with a Remote Controlled Robot
2016
Molecular Grading of Urothelial Cell Carcinoma With Fibroblast Growth Factor Receptor 3 and MIB-1 is Superior to Pathologic Grade for the Prediction of Clinical Outcome
2003
Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology Classification System for Urothelial Neoplasia.
2001
Laparoscopic Versus Open Radical Prostatectomy: A Comparative Study at a Single Institution
2003
Prognostic Factors for Recurrence and Followup Policies in the Treatment of Superficial Bladder Cancer: Report from the British Medical Research Council Subgroup On Superficial Bladder Cancer (Urological Cancer Working Party)
1989
LAPAROSCOPIC RADICAL PROSTATECTOMY WITH A REMOTE CONTROLLED ROBOT
2001
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Laparoscopic and Robot Assisted Radical Prostatectomy: Establishment of a Structured Program and Preliminary Analysis of Outcomes
2002
INHIBITION OF BLADDER CARCINOMA CELL ADHESION BY OLIGOPEPTIDE COMBINATIONS IN VITRO AND IN VIVO
2002
LAPAROSCOPIC RADICAL CYSTECTOMY WITH CONTINENT URINARY DIVERSION (RECTAL SIGMOID POUCH) PERFORMED COMPLETELY INTRACORPOREALLY: THE INITIAL 5 CASES
2001
SEXTANT LOCALIZATION OF PROSTATE CANCER: COMPARISON OF SEXTANT BIOPSY, MAGNETIC RESONANCE IMAGING AND MAGNETIC RESONANCE SPECTROSCOPIC IMAGING WITH STEP SECTION HISTOLOGY
2000
Image-Guided Interventions: Technology Review and Clinical Applications
2010
p53 Immunohistochemistry as a Prognostic Marker in Bladder Cancer
2000
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
2002 Standout
UROLOGICAL COMPLICATIONS OF LAPAROSCOPIC SURGERY: EXPERIENCE WITH 350 PROCEDURES AT A SINGLE CENTER
2001
[Remote laparoscopic radical prostatectomy carried out with a robot. Report of a case].
2000
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
THE ROLE AND IMPACT OF PATHOLOGY REVIEW ON STAGE AND GRADE ASSESSMENT OF STAGES TA AND T1 BLADDER TUMORS: A COMBINED ANALYSIS OF 5 EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER TRIALS
2000
Prognostic Factors in Non–Muscle-Invasive Bladder Tumors
2007
Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials
2002 Standout
MULTIVARIATE ANALYSIS OF THE PROGNOSTIC FACTORS OF PRIMARY SUPERFICIAL BLADDER CANCER
2000
Impact of obesity on clinical outcomes in robotic prostatectomy
2005 StandoutNobel
Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
2015 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of J Bellot being referenced
Laparoscopic radical prostatectomy: preliminary results
2000
Value of Ultrasound-Guided Systematic Sextant Biopsies in Prostate Tumor Mapping
1999
Pretreatment p53 Nuclear Overexpression as a Prognostic Marker in Superficial Bladder Cancer Treated with Bacillus Calmette–Guérin (BCG)
2003
Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer
1995
Prognostic factors in superficial bladder cancer
1993
Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki-67 antibody
1994
[Natural history and prognostic factors of superficial tumors of the bladder].
1993
The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder
1997
[Results of treatment of superficial vesical tumors by transurethral resection alone and transurethral resection followed by an intravesical instillation of Calmette-Guerin bacillus].
1990
[Prognostic value of a positive single ultrasound-guided prostatic biopsy regarding tumor volume and intracapsular nature of prostatic adenocarcinoma].
1996